These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32297166)

  • 1. Treatment of Alzheimer's diseases using donepezil nanoemulsion: an intranasal approach.
    Kaur A; Nigam K; Bhatnagar I; Sukhpal H; Awasthy S; Shankar S; Tyagi A; Dang S
    Drug Deliv Transl Res; 2020 Dec; 10(6):1862-1875. PubMed ID: 32297166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine nanoemulsion: a new approach to treat Alzheimer's disease.
    Kaur A; Nigam K; Srivastava S; Tyagi A; Dang S
    J Microencapsul; 2020 Aug; 37(5):355-365. PubMed ID: 32293915
    [No Abstract]   [Full Text] [Related]  

  • 3. The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.
    Jiang Y; Liu C; Zhai W; Zhuang N; Han T; Ding Z
    Int J Nanomedicine; 2019; 14():9217-9234. PubMed ID: 31819426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Intranasal Codelivery of Donepezil and Memantine in a Nanocolloidal Carrier: Optimization, Pharmacokinetics, and Pharmacodynamics Studies.
    Handa M; Sanap SN; Bhatta RS; Patil GP; Palkhade R; Singh DP; Shukla R
    Mol Pharm; 2023 Sep; 20(9):4714-4728. PubMed ID: 37523676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.
    Sharma D; Sharma RK; Sharma N; Gabrani R; Sharma SK; Ali J; Dang S
    AAPS PharmSciTech; 2015 Oct; 16(5):1108-21. PubMed ID: 25698083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and development of letrozole nanoemulsion: A comparative evaluation of brain targeted nanoemulsion with free letrozole against status epilepticus and neurodegeneration in mice.
    Iqbal R; Ahmed S; Jain GK; Vohora D
    Int J Pharm; 2019 Jun; 565():20-32. PubMed ID: 31051232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation.
    Salem HF; Aboud HM; Abdellatif MM; Abou-Taleb HA
    J Pharm Sci; 2024 Jul; 113(7):1934-1945. PubMed ID: 38369023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
    Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
    Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefenamic Acid Loaded and TPGS Stabilized Mucoadhesive Nanoemulsion for the Treatment of Alzheimer's Disease: Development, Optimization, and Brain-Targeted Delivery via Olfactory Pathway.
    Dogra A; Narang RS; Kaur T; Narang JK
    AAPS PharmSciTech; 2024 Jan; 25(1):16. PubMed ID: 38200387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravaginal Delivery of Polyphenon 60 and Curcumin Nanoemulsion Gel.
    Kaur A; Saxena Y; Bansal R; Gupta S; Tyagi A; Sharma RK; Ali J; Panda AK; Gabrani R; Dang S
    AAPS PharmSciTech; 2017 Aug; 18(6):2188-2202. PubMed ID: 28070848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Preliminary Pharmacodynamic Study for the Management of Alzheimer's Disease Using Memantine-Loaded PLGA Nanoparticles.
    Kaur A; Nigam K; Tyagi A; Dang S
    AAPS PharmSciTech; 2022 Nov; 23(8):298. PubMed ID: 36380129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability and antihypertensive activity of nisoldipine loaded nanoemulsion: optimization, cytotoxicity and uptake across Caco-2 cell line, pharmacokinetic and pharmacodynamic studies.
    Mundada VP; Patel MH; Mundada PK; Sawant KK
    Drug Dev Ind Pharm; 2020 Mar; 46(3):376-387. PubMed ID: 32031412
    [No Abstract]   [Full Text] [Related]  

  • 14. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osthole-Loaded Nanoemulsion Enhances Brain Target in the Treatment of Alzheimer's Disease via Intranasal Administration.
    Song Y; Wang X; Wang X; Wang J; Hao Q; Hao J; Hou X
    Oxid Med Cell Longev; 2021; 2021():8844455. PubMed ID: 33564364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosemary oil low energy nanoemulsion: optimization, µrheology,
    Vasdev N; Handa M; Kesharwani P; Shukla R
    J Biomater Sci Polym Ed; 2022 Oct; 33(15):1901-1923. PubMed ID: 35686513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization.
    Shah BM; Misra M; Shishoo CJ; Padh H
    Drug Deliv; 2015; 22(7):918-30. PubMed ID: 24467601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
    Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J
    Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation.
    Pandey YR; Kumar S; Gupta BK; Ali J; Baboota S
    Nanotechnology; 2016 Jan; 27(2):025102. PubMed ID: 26629830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer's Disease: in vitro and ex vivo Characterization.
    Espinoza LC; Vacacela M; Clares B; Garcia ML; Fabrega MJ; Calpena AC
    CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):43-53. PubMed ID: 29299992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.